3rd Quarter - Termination Amendment

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for TAKEDA PHARMACEUTICAL COMPANY, LIMITED

Firm
Client
Income
$30,000
Expenses
—
Terminated
Sep 30, 2008

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Termination Oct 20, 2008 $30,000 Replaced
3rd Quarter - Termination Amendment (this page) Feb 3, 2009 $30,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Least costly alternative policies

Foreign entity interest: Takeda Pharmaceutical Company Limited has the same interest as Takeda Pharmaceuticals North America.

LobbyistCovered position, as disclosed
MICHAEL J BELL —
ROBERT D. KYLE —
KATHLEEN M MCAULIFFE —
GWEN E MELLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.